project id: TCGA-ACC; case submitter id: TCGA-OR-A5L4; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 9.1; age at index: 48; days to birth: -17819; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 17819; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T4; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 967.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 456; initial weight: 80.0; sample id: 3be50768-a2b0-4498-a5e8-d5ba86e8680c; sample submitter id: TCGA-OR-A5L4-01A; portion id: 6da654c2-9e3a-46d7-a973-703d9beb7d99; portion submitter id: TCGA-OR-A5L4-01A-11; slide id: b83aba93-f744-4816-9d13-f5cc8a8453db; slide submitter id: TCGA-OR-A5L4-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0; section location: TOP;